Ian Robins

653 total citations
9 papers, 85 citations indexed

About

Ian Robins is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Ian Robins has authored 9 papers receiving a total of 85 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 5 papers in Pulmonary and Respiratory Medicine and 2 papers in Oncology. Recurrent topics in Ian Robins's work include Glioma Diagnosis and Treatment (5 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Medical Imaging Techniques and Applications (2 papers). Ian Robins is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Medical Imaging Techniques and Applications (2 papers). Ian Robins collaborates with scholars based in United States and Germany. Ian Robins's co-authors include Thomas Feyerabend, Patrick Y. Wen, Timothy F. Cloughesy, G. Wiedemann, Larry Junck, Eckart Richter, Thomas Wagner, Richard A. Steeves, W.K. Alfred Yung and John G. Kuhn and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Oncology and Oncology.

In The Last Decade

Ian Robins

8 papers receiving 82 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ian Robins United States	6	39	33	29	22	20	9	85
Ziad Thotathil New Zealand	7	29 0.7×	24 0.7×	26 0.9×	11 0.5×	33 1.6×	13	112
Stacey Green United States	3	53 1.4×	31 0.9×	16 0.6×	18 0.8×	17 0.8×	4	74
Emanuela Pozzi Switzerland	3	26 0.7×	22 0.7×	48 1.7×	26 1.2×	37 1.9×	5	90
Marco Matos Australia	4	43 1.1×	17 0.5×	19 0.7×	26 1.2×	27 1.4×	8	72
Elke Pfaff Germany	4	84 2.2×	48 1.5×	30 1.0×	56 2.5×	26 1.3×	10	131
Lien Solie Belgium	6	50 1.3×	45 1.4×	18 0.6×	17 0.8×	23 1.1×	8	131
S. C. Erridge United Kingdom	4	109 2.8×	41 1.2×	53 1.8×	33 1.5×	14 0.7×	5	129
Melitta Kitzwoegerer Austria	6	30 0.8×	38 1.2×	10 0.3×	12 0.5×	17 0.8×	6	119
Hussain AlHussain Saudi Arabia	6	25 0.6×	30 0.9×	20 0.7×	35 1.6×	12 0.6×	12	78
Orazio Santo Santonocito Italy	5	36 0.9×	29 0.9×	12 0.4×	23 1.0×	7 0.3×	23	83

Countries citing papers authored by Ian Robins

Since Specialization

Citations

This map shows the geographic impact of Ian Robins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Robins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Robins more than expected).

Fields of papers citing papers by Ian Robins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Robins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Robins. The network helps show where Ian Robins may publish in the future.

Co-authorship network of co-authors of Ian Robins

This figure shows the co-authorship network connecting the top 25 collaborators of Ian Robins. A scholar is included among the top collaborators of Ian Robins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Robins. Ian Robins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Robins, Ian. (2016). Karenitecin (bnp1350) and flavopridol as radiosensitizers in malignant glioma. PubMed. 1(6). 1–10. 2 indexed citations

2.

Chang, Shi, John G. Kuhn, Kathleen R. Lamborn, et al.. (2009). Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas (MG) (NABTC 04–02). Journal of Clinical Oncology. 27(15_suppl). 2004–2004. 13 indexed citations

3.

Chang, Shannon, Kathleen R. Lamborn, Patrick Y. Wen, et al.. (2006). Phase II study of POLY-ICLC in recurrent anaplastic glioma–A North American Brain Tumor Consortium study. Journal of Clinical Oncology. 24(18_suppl). 1550–1550. 1 indexed citations

4.

Yung, W.K. Alfred, Patrick Y. Wen, Larry Junck, et al.. (2004). Phase I study of ZD1839 plus temozolomide in patients with malignant glioma. A study of the North American Brain Tumor Consortium. Journal of Clinical Oncology. 22(14_suppl). 1504–1504. 7 indexed citations

5.

Prados, Michael D., W.K. Alfred Yung, Patrick Y. Wen, et al.. (2004). Phase I study of ZD1839 plus temozolomide in patients with malignant glioma. A study of the North American Brain Tumor Consortium. Journal of Clinical Oncology. 22(14_suppl). 1504–1504. 19 indexed citations

6.

Peters, Stefan, Ian Robins, Günther Wiedemann, et al.. (2001). A preclinical model for experimental chemotherapy of human head and neck cancer. International Journal of Oncology. 18(6). 1145–9. 16 indexed citations

7.

Robins, Ian, et al.. (2000). Wild classics : traditional and easy recipes with a bush food difference. Allen & Unwin eBooks.

8.

Sanghavi, Seema, et al.. (1999). Recurrent Malignant Gliomas Treated with Radiosurgery. 2(3). 119–125. 9 indexed citations

9.

Feyerabend, Thomas, Richard A. Steeves, G. Wiedemann, et al.. (1996). Local Hyperthermia, Radiation, and Chemotherapy in Locally Advanced Malignancies. Oncology. 53(3). 214–220. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact